Cardurion Pharmaceuticals

Cardurion Pharmaceuticals

Biotechnology Research

Burlington, Massachusetts 2,170 followers

Translating the science of cardiac myocyte signaling pathways into groundbreaking therapeutics

About us

Cardurion Pharmaceuticals is a next generation cardiovascular company focused on the discovery and development of novel therapeutics for the treatment of heart failure and other cardiovascular diseases. Led by an experienced team of CV experts and industry veterans, we are developing groundbreaking clinical programs in PDE9 and CaMKII inhibition. We take a strategic portfolio approach driven by in-house drug discovery and our office of strategy and have concluded foundational partnerships with key strategics and investors, including an up to $300 million dollar investment from Bain Capital to support current programs and pipeline growth. Cardurion Pharmaceuticals has facilities in Burlington, Massachusetts and Shonan, Japan. For more information, please visit the company’s website at http://www.cardurion.com.

Website
http://www.cardurion.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Burlington, Massachusetts
Type
Privately Held
Founded
2017
Specialties
Biotechnology, Therapeutics, Cardiovascular, Heart Failure, and Cardiology

Locations

  • Primary

    78 Blanchard Road

    Suite 200

    Burlington, Massachusetts 01803, US

    Get directions
  • 26-1, Muraoka-Higashi 2-chome

    Fujisawa, Kanagawa 251-8555, JP

    Get directions

Employees at Cardurion Pharmaceuticals

Updates

Similar pages

Browse jobs

Funding

Cardurion Pharmaceuticals 5 total rounds

Last Round

Debt financing

US$ 17.5M

See more info on crunchbase